treatment , patient and the disease landscape . “ Deriving insights from valuable data through collaborations is at the heart of modern data-driven healthcare , but it is increasingly challenging due to globally strengthening data privacy regulation . We are excited by the partnering with Tel Aviv Sourasky Medical Center , as it unlocks a new , agile and secure way for organisations to collaborate on healthcare data , while complying with regulation ,” said Rina Shainski , Chairwoman and Co-founder at Duality . “ Our company ’ s mission has always been to deliver highest-quality technological solutions addressing the challenges of trust , safety and compliance in data collaborations . This partnership will enable TASMC agile participation in collaborative medical research , multi-centre studies , cross-border initiatives and more .”

Dr Ravit Geva , Deputy Director of the Oncology Division and heading the Clinical Research and Innovation unit of the oncology division , said : “ There is always a gap between promise and reality with

Big Data . We need to be able to combine data from different centres with good quality and still respecting the privacy-related interests of individuals whose data we are using and preserving data ownership . Our joint study with Duality aimed and verified the accuracy of statistical oncology endpoint when done through encrypted data . The secure analysis was compared with the currently internally used conventional data management and analysis methods on Collaborative Real-world Oncological Survival analysis without revealing patients ’ protected health information .”

Tel Aviv Sourasky Medical Center is world-renowned for top quality medical care and for leadership in technology innovation .

www . intelligentcio . com INTELLIGENTCIO EUROPE 51